Skip to content

Current ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-0.2×
Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
6.7×+4.4×
UroGen Pharma logo
UroGen PharmaURGN
4.7×-1.0×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
10.7×-3.2×
CG Oncology logo
CG OncologyCGON
31.3×+0.3×

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×

Where this comes from

Calculated from Aura Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s current ratio?
Aura Biosciences, Inc. (AURA) reported current ratio of 7.1× in Q1 2026.
How has Aura Biosciences, Inc.'s current ratio changed year-over-year?
Aura Biosciences, Inc.'s current ratio decreased by 35.9% year-over-year, from 11.1× to 7.1×.
What is the long-term trend for Aura Biosciences, Inc.'s current ratio?
Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s current ratio has grown at a 3.3% compound annual growth rate (CAGR), from 6.9× to 8.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.